The effects of activated protein C on the von Willebrand factor and von Willebrand factor cleaving protease of rat aortic endothelial cell induced by lipopolysaccharide

Chinese Critical Care Medicine

Volumn 24, Issue 8, 2012, Pages 487-489

  Zheng, Gui Jun ^a   Wu, Zi Xia ^b   Zhu, Hai Yun ^b   Yin, Dong Mei ^b   Sun, Qian ^b   Li, Yin Ping ^b  

^a Zhuozhou City Hospital of Hebei Province   (China)

^b NONE

Author keywords

Activated protein C; Aortic endothelial cell; Lipopolysaccharide; Rat; Von Willebrand factor; Von Willebrand factor cleaving protease

Indexed keywords

ACTIVATED PROTEIN C; LIPOPOLYSACCHARIDE; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE; ADAM PROTEIN; ADAMTS13 PROTEIN, RAT; PROTEIN C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; DOSE RESPONSE; ENDOTHELIUM CELL; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; NONHUMAN; PROTEIN EXPRESSION; RAT; SUPERNATANT; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; MALE; METABOLISM; WISTAR RAT;

ADAM PROTEINS; ANIMALS; AORTA; CELLS, CULTURED; ENDOTHELIAL CELLS; LIPOPOLYSACCHARIDES; MALE; PROTEIN C; RATS; RATS, WISTAR; VON WILLEBRAND FACTOR;

EID: 84866536838     PISSN: 10030603     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.1003-0603.2012.08.011     Document Type: Article

References (14)

1. Aird WC. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood,2003,101:3765-3777.
2. Coughlin SR. Thrombin signalling and protease-activated receptors. Nature,2000,407:258-264.
3. Xue M, Campbell D, Sambrook PN, et al. Endothelial protein C receptor and protease-activated receptor-1 mediate induction of a wound-healing phenotype in human keratinocytes by activated protein C. J Invest Dermatol,2005,125:1279- 1285.
4. Faust SN, Levin M, Harrison OB, et al. Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med,2001,345:408-416.
5. van Veen SQ, Levi M, van Vliet AK, et al. Peritoneal lavage with activated protein C alters compartmentalized coagulation and fibrinolysis and improves survival in polymicrobial peritonitis. Crit Care Med,2006,34:2799-2805.
6. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med,2001,344:699-709.
7. Sadler JE. von Willebrand factor assembly and secretion. J Thromb Haemost,2009,7 Suppl 1:24-27.
8. Giblin JP, Hewlett LJ, Hannah MJ. Basal secretion of von Willebrand factor from human endothelial cells. Blood,2008,112:957-964.
9. Zheng X, Chung D, Takayama TK, et al. Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura. J Biol Chem,2001,276:41059-41063.
10. Moore JC, Hayward CP, Warkentin TE, et al. Decreased von Willebrand factor protease activity associated with thrombocytopenic disorders. Blood,2001,98:1842-1846.